LambdaVision logo

LambdaVision

LambdaVision develops protein-based artificial retinas to treat blindness using microgravity manufacturing.

Farmington, United States Est. 2009 Commercial
Visit Website
Quick Facts
Country
United States
Founded
2009
Type
commercial
Status
operational

About LambdaVision

LambdaVision develops protein-based artificial retinas to treat blindness using microgravity manufacturing. The company produces highly uniform multilayered protein films in space that are impossible to create on Earth. With 9 ISS missions completed and $7M raised in 2025, LambdaVision is pioneering space-based biomedical manufacturing.

Categories & Capabilities

Location

Loading map...

Click and drag to explore • Double-click to zoom

Share

Suggest an Edit

Is this information outdated or incorrect? Help us improve this profile.

Submit Correction

Explore More

Discover 1,000+ space companies worldwide

Browse All Companies

Frequently asked about LambdaVision

Quick answers to the questions readers most often search for.

When was LambdaVision founded?
LambdaVision was founded in 2009 in United States.
Where is LambdaVision headquartered?
LambdaVision is headquartered in Farmington, United States.
What does LambdaVision do?
LambdaVision develops protein-based artificial retinas to treat blindness using microgravity manufacturing. The company produces highly uniform multilayered protein films in space that are impossible to create on Earth. With 9 ISS missions completed and $7M raised in 2025, LambdaVision is pioneering space-based biomedi…
Is LambdaVision a public or private company?
LambdaVision is currently a private commercial (status: operational).
What sector does LambdaVision operate in?
LambdaVision operates in in-space-manufacturing, biotechnology.

Data Accuracy Notice: Information about LambdaVision is compiled from publicly available sources including company websites, press releases, regulatory filings, and industry reports. Data is reviewed periodically but may not reflect the most recent developments.

Last updated: May 29, 2026
Company representatives may submit corrections This page does not constitute an endorsement or affiliation Learn about our data methodology